Europe Hospital-acquired Disease Testing Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Hospital-acquired Disease Testing Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Type I Market Performance (Volume)
  • 2.1.2 Type II Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Type I Market Performance (Value)
  • 2.1.2 Type II Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Application 1 Market Performance (Volume)
  • 3.1.2 Application 2 Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Abbott Laboratories
  • 4.1.1 Abbott Laboratories Profiles
  • 4.1.2 Abbott Laboratories Product Information
  • 4.1.3 Abbott Laboratories Hospital-acquired Disease Testing Business Performance
  • 4.1.4 Abbott Laboratories Hospital-acquired Disease Testing Business Development and Market Status
• 4.2 Becton and Dickenson
  • 4.2.1 Becton and Dickenson Profiles
  • 4.2.2 Becton and Dickenson Product Information
  • 4.2.3 Becton and Dickenson Hospital-acquired Disease Testing Business Performance
  • 4.2.4 Becton and Dickenson Hospital-acquired Disease Testing Business Development and Market Status
• 4.3 BioMerieux
  • 4.3.1 BioMerieux Profiles
  • 4.3.2 BioMerieux Product Information
  • 4.3.3 BioMerieux Hospital-acquired Disease Testing Business Performance
  • 4.3.4 BioMerieux Hospital-acquired Disease Testing Business Development and Market Status
• 4.4 Roche Diagnostics
  • 4.4.1 Roche Diagnostics Profiles
  • 4.4.2 Roche Diagnostics Product Information
  • 4.4.3 Roche Diagnostics Hospital-acquired Disease Testing Business Performance
  • 4.4.4 Roche Diagnostics Hospital-acquired Disease Testing Business Development and Market Status
• 4.5 Akers Biosciences
  • 4.5.1 Akers Biosciences Profiles
  • 4.5.2 Akers Biosciences Product Information
  • 4.5.3 Akers Biosciences Hospital-acquired Disease Testing Business Performance
  • 4.5.4 Akers Biosciences Hospital-acquired Disease Testing Business Development and Market Status
• 4.6 Alere
  • 4.6.1 Alere Profiles
  • 4.6.2 Alere Product Information
  • 4.6.3 Alere Hospital-acquired Disease Testing Business Performance
  • 4.6.4 Alere Hospital-acquired Disease Testing Business Development and Market Status
• 4.7 Beckman Coulter/Danaher
  • 4.7.1 Beckman Coulter/Danaher Profiles
  • 4.7.2 Beckman Coulter/Danaher Product Information
  • 4.7.3 Beckman Coulter/Danaher Hospital-acquired Disease Testing Business Performance
  • 4.7.4 Beckman Coulter/Danaher Hospital-acquired Disease Testing Business Development and Market Status
• 4.8 Cantel Medical
  • 4.8.1 Cantel Medical Profiles
  • 4.8.2 Cantel Medical Product Information
  • 4.8.3 Cantel Medical Hospital-acquired Disease Testing Business Performance
  • 4.8.4 Cantel Medical Hospital-acquired Disease Testing Business Development and Market Status
• 4.9 Cepheid
  • 4.9.1 Cepheid Profiles
  • 4.9.2 Cepheid Product Information
  • 4.9.3 Cepheid Hospital-acquired Disease Testing Business Performance
  • 4.9.4 Cepheid Hospital-acquired Disease Testing Business Development and Market Status
• 4.10 Diatherix Laboratories
  • 4.10.1 Diatherix Laboratories Profiles
  • 4.10.2 Diatherix Laboratories Product Information
  • 4.10.3 Diatherix Laboratories Hospital-acquired Disease Testing Business Performance
  • 4.10.4 Diatherix Laboratories Hospital-acquired Disease Testing Business Development and Market Status
• 4.11 Eiken Chemical
• 4.12 Enzo Biochem
• 4.13 BioMerieux
• 4.14 Roche Diagnostics
• 4.15 Akers Biosciences

5 Market Performance for Manufacturers

• 5.1 Europe Hospital-acquired Disease Testing Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Europe Hospital-acquired Disease Testing Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Europe Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Europe Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany Hospital-acquired Disease Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Germany Hospital-acquired Disease Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Germany Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Germany Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK Hospital-acquired Disease Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 UK Hospital-acquired Disease Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 UK Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 UK Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France Hospital-acquired Disease Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 France Hospital-acquired Disease Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 France Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 France Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia Hospital-acquired Disease Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Russia Hospital-acquired Disease Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Russia Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Russia Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux Hospital-acquired Disease Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Benelux Hospital-acquired Disease Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Benelux Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Benelux Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy Hospital-acquired Disease Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Italy Hospital-acquired Disease Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Italy Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Italy Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain Hospital-acquired Disease Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Spain Hospital-acquired Disease Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Spain Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Spain Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Hospital-acquired Disease Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Hospital-acquired Disease Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Europe Hospital-acquired Disease Testing Market Performance (Sales Point)

• 7.1 Europe Hospital-acquired Disease Testing Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Europe Hospital-acquired Disease Testing Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Europe Hospital-acquired Disease Testing Price (USD/Unit) by Regions 2013-2018
• 7.4 Europe Hospital-acquired Disease Testing Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Europe Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Germany Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 UK Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 France Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Russia Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Benelux Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Italy Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Application 1 Industry
• 11.2 Application 2 Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Europe Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Europe Hospital-acquired Disease Testing Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Germany Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 UK Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 France Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Russia Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Benelux Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Italy Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Spain Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Application 1 Sales and and Growth Rate 2019-2024
  • 12.4.3 Application 2 Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Europe Hospital-acquired Disease Testing Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Europe Hospital-acquired Disease Testing Gross Profit Trend 2019-2024

13 Conclusion